Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 21 April, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Alpa Laboratories Ltd

About the Company - Alpa Laboratories Ltd

Alpa Laboratories Ltd. is a Public Limited Listed company incorporated on 18/03/1988 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L85195MP1988PLC004446 and registration number is 004446. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 112.27 Cr. and Equity Capital is Rs. 21.04 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Pharmaceuticals33/2, Pigdamber, Indore Madhya Pradesh 453446is@alpalabs.in
http://www.alpalabs.in
Management
NamePosition Held
Mr. Mahendra Singh ChawlaChairman
Mr. Paresh ChawlaManaging Director
Mr. Devendra BahetiIndependent Director
Mr. Sharad Chand LunawatIndependent Director
Mr. Krishna Das MalaniIndependent Director
Mrs. Jyoti JainIndependent Director
Mr. Pravin ShahDirector
Mr. Vitthal KothanaDirector
Mr. Sanket BahetiIndependent Director
Mr. Shitul ShahWhole Time Director
Mr. Sunil Kumar ValechaIndependent Director
Mrs. Pratibha LunawatIndependent Director

Alpa Laboratories Ltd. Share Price Update

Share PriceValue
Today₹91.91
Previous Day₹89.46

Basic Stock Data of Alpa Laboratories Ltd

Last Updated: April 6, 2024, 5:47 am

Market Cap 200 Cr.
Current Price 95.0
High / Low115/53.6
Stock P/E11.2
Book Value 72.9
Dividend Yield0.00 %
ROCE8.99 %
ROE7.26 %
Face Value 10.0

Data Source: screener.in

Alpa Laboratories Ltd Quarterly Results

MonthSep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Sales23.1133.1624.9931.5226.2629.3325.5022.4213.5427.3129.1625.4332.39
Expenses21.3730.2323.7628.9822.7325.6126.8621.0019.2824.6819.9026.5829.07
Operating Profit1.742.931.232.543.533.72-1.361.42-5.742.639.26-1.153.32
OPM %7.53%8.84%4.92%8.06%13.44%12.68%-5.33%6.33%-42.39%9.63%31.76%-4.52%10.25%
Other Income0.871.180.644.262.702.203.721.616.382.69-0.764.472.95
Interest0.030.030.020.040.060.080.070.030.080.070.040.020.04
Depreciation0.290.310.350.310.420.430.500.340.360.100.530.280.49
Profit before tax2.293.771.506.455.755.411.792.660.205.157.933.025.74
Tax %-0.00%-0.00%235.33%-0.00%-0.00%-0.00%304.47%-0.00%-0.00%-0.00%41.74%-0.00%-0.00%
Net Profit2.293.77-2.036.455.755.41-3.662.660.205.144.623.035.74
EPS in Rs1.091.79-0.963.072.732.57-1.741.260.102.442.201.442.73

Alpa Laboratories Ltd Quarterly Chart

Alpa Laboratories Ltd Profit & Loss

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales5556565753636277859711293114
Expenses5353515447565776799010185100
Operating Profit336377416811814
OPM %5%5%10%6%13%11%7%2%7%8%10%9%12%
Other Income10126455041199
Interest1222121100000
Depreciation1596111111211
Profit before tax1-3-5-311975511201622
Tax %37%-36%-4%48%27%34%27%36%20%33%28%21%
Net Profit1-4-5-1865347141319
EPS in Rs0.25-2.08-2.45-0.673.682.852.271.401.943.456.726.008.81
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%0%

Alpa Laboratories Ltd Profit & Loss Yearly Chart

Alpa Laboratories Ltd Growth

Compounded Sales Growth
10 Years:5%
5 Years:9%
3 Years:3%
TTM:29%
Compounded Profit Growth
10 Years:16%
5 Years:15%
3 Years:23%
TTM:312%
Stock Price CAGR
10 Years:25%
5 Years:28%
3 Years:22%
1 Year:52%
Return on Equity
10 Years:4%
5 Years:5%
3 Years:6%
Last Year:7%

Last Updated: April 6, 2024, 5:47 am

Alpa Laboratories Ltd Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital21212121212121212121212121
Reserves77726766737782858996111123132
Borrowings1217232924116200632
Other Liabilities20141513272017212133283039
Total Liabilities130125127128145129127129131150165178194
Fixed Assets980735556667977
CWIP59000000012000
Investments000102223415968628690117
Other Assets62455411311810079645680708170
Total Assets130125127128145129127129131150165178194

Alpa Laboratories Ltd Reserves and Borrowings Chart

Alpa Laboratories Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity -138-2-25-8-7-118-129
Cash from Investing Activity -1-4-237-71-16-15-116-162
Cash from Financing Activity 1247-6-24-5-1-05-3
Net Cash Flow-101042-37-9-19-2054-87

Alpa Laboratories Ltd Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days142127130156234169151141105133124184
Inventory Days14213214876196131140105901028184
Days Payable1428512191244140130999815278100
Cash Conversion Cycle1421741571411871601611489783127168
Working Capital Days265187169178390256234194121137136155
ROCE %2%-1%-3%0%10%11%7%4%7%7%9%9%

Alpa Laboratories Ltd Financial Efficiency Indicators Chart

Alpa Laboratories Ltd Share Holding Pattern

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Promoters56.66%56.66%56.66%56.66%57.29%57.29%57.29%57.29%57.29%57.29%57.29%57.29%
FIIs0.00%0.00%0.00%0.09%0.56%0.21%0.14%0.00%0.00%0.00%0.11%0.95%
DIIs0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.01%0.00%0.00%
Government0.00%0.00%0.00%0.05%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Public43.34%43.34%43.34%43.20%42.15%42.50%42.56%42.70%42.70%42.70%42.59%41.74%
No. of Shareholders13,24015,54715,59516,11418,77518,79618,84019,09419,13718,74518,56518,682

Alpa Laboratories Ltd Shareholding Pattern Chart

No. of Alpa Laboratories Ltd Shareholders

This stock is not held by any mutual fund

Alpa Laboratories Ltd ROCE Trend

Alpa Laboratories Ltd EPS Trend

Alpa Laboratories Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)5.906.703.440.880.37
Diluted EPS (Rs.)5.906.703.440.890.37
Cash EPS (Rs.)6.637.484.032.381.86
Book Value[Excl.RevalReserv]/Share (Rs.)63.9657.8551.1647.7046.71
Book Value[Incl.RevalReserv]/Share (Rs.)63.9657.8551.1647.7046.71
Revenue From Operations / Share (Rs.)43.9353.3646.3640.8637.06
PBDIT / Share (Rs.)8.3110.195.752.982.96
PBIT / Share (Rs.)7.689.405.161.481.48
PBT / Share (Rs.)7.589.305.131.381.21
Net Profit / Share (Rs.)6.006.703.440.880.37
NP After MI And SOA / Share (Rs.)6.006.703.440.880.37
PBDIT Margin (%)18.9119.0912.397.297.98
PBIT Margin (%)17.4817.6111.133.613.98
PBT Margin (%)17.2417.4211.053.383.25
Net Profit Margin (%)13.6612.557.422.151.01
NP After MI And SOA Margin (%)13.6612.557.422.151.01
Return on Networth / Equity (%)9.3811.576.731.840.80
Return on Capital Employeed (%)11.8015.9710.073.083.14
Return On Assets (%)7.549.075.161.520.65
Long Term Debt / Equity (X)0.010.010.000.000.00
Total Debt / Equity (X)0.010.040.000.000.01
Asset Turnover Ratio (%)0.550.730.710.680.62
Current Ratio (X)4.984.433.734.594.22
Quick Ratio (X)4.563.933.223.993.59
Inventory Turnover Ratio (X)3.893.963.733.723.35
Interest Coverage Ratio (X)78.2897.84155.2431.9510.95
Interest Coverage Ratio (Post Tax) (X)57.5565.3294.0310.452.40
Enterprise Value (Cr.)105.31149.5765.5623.6956.32
EV / Net Operating Revenue (X)1.141.330.670.270.72
EV / EBITDA (X)6.026.985.423.789.05
MarketCap / Net Operating Revenue (X)1.221.300.770.340.71
Price / BV (X)0.841.200.700.290.56
Price / Net Operating Revenue (X)1.221.300.770.340.71
EarningsYield0.110.090.090.060.01

Alpa Laboratories Ltd Profitability Ratios (%)

Alpa Laboratories Ltd Liquidity Ratios

Alpa Laboratories Ltd Liquidity Ratios (%)

Alpa Laboratories Ltd Interest Coverage Ratios (%)

Alpa Laboratories Ltd Valuation Ratios

Strength and Weakness of Alpa Laboratories Ltd Stock

StrengthWeakness
  1. The company has higher reserves (88.46 cr) compared to borrowings (10.38 cr), indicating strong financial stability.
  2. The company has shown consistent growth in sales (75.38 cr) and profit (7.38 cr) over the years.
  1. The stock has a low average ROCE of 5.17%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 201.83, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 145.42, which may not be favorable.

FAQ

What is the latest fair value of Alpa Laboratories Ltd?

The latest fair value of Alpa Laboratories Ltd is 0.00.

What is the Market Cap of Alpa Laboratories Ltd?

The Market Cap of Alpa Laboratories Ltd is 200 Cr..

What is the current Stock Price of Alpa Laboratories Ltd as on 17 April 2024?

The current stock price of Alpa Laboratories Ltd as on 17 April 2024 is 95.0.

What is the High / Low of Alpa Laboratories Ltd stocks in FY 2024?

In FY 2024, the High / Low of Alpa Laboratories Ltd stocks is ₹115/53.6.

What is the Stock P/E of Alpa Laboratories Ltd?

The Stock P/E of Alpa Laboratories Ltd is 11.2.

What is the Book Value of Alpa Laboratories Ltd?

The Book Value of Alpa Laboratories Ltd is 72.9.

What is the Dividend Yield of Alpa Laboratories Ltd?

The Dividend Yield of Alpa Laboratories Ltd is 0.00 %.

What is the ROCE of Alpa Laboratories Ltd?

The ROCE of Alpa Laboratories Ltd is 8.99 %.

What is the ROE of Alpa Laboratories Ltd?

The ROE of Alpa Laboratories Ltd is 7.26 %.

What is the Face Value of Alpa Laboratories Ltd?

The Face Value of Alpa Laboratories Ltd is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Alpa Laboratories Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE